PHARMHELP
The computed 12-month bankruptcy probability of PHARMHELP is 1.1% (low). The 2024 annual accounts show equity of €22k and a net result of €17k. Its solvency ranks better than 39% of 192 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €22k |
| Net result | €17k |
| Staff (FTE) | 1 |
| Better than sector | 39% |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 18.7% | 32.1% | |
| Net result | €17k | €26k | |
| Equity | €22k | €121k | |
| Gross operating margin | €254k | €72k | |
| Staff costs | €226k | €221k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €28k |
| Net profit | €17k |
| Cash flow | €18k |
| Staff costs | €226k |
| Income taxes | €6k |
| Dividends | - |
| Total assets | €118k |
| Equity | €22k |
| Debt | €96k |
| of which ≤ 1y | €96k |
| of which > 1y | - |
| Working capital | €19k |
| Employees (FTE) | 1.0 |
| 2024 | |
|---|---|
| Current ratio | 1.20 |
| Quick ratio | 1.20 |
| Working capital ratio | 16.3% |
| Solvency | 18.7% |
| Debt / equity | 4.35 |
| Long-term debt ratio | - |
| Interest coverage | 7.04 |
| Gross margin | - |
| Net margin | - |
| ROA | 14.7% |
| ROE | 78.8% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €118k |
| Fixed assets | 21/28 | €3k |
| Tangible fixed assets | 22/27 | €3k |
| Financial fixed assets | 28 | €200 |
| Current assets | 29/58 | €115k |
| Amounts receivable within one year | 40/41 | €46k |
| Investments | 50/53 | €2k |
| Cash & bank | 54/58 | €54k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €118k |
| Equity | 10/15 | €22k |
| Contributions / capital | 10/11 | €9k |
| Accumulated profits (losses) | 14 | €14k |
| Amounts payable | 17/49 | €96k |
| Amounts payable within one year | 42/48 | €96k |
| Trade debts payable within one year | 44 | €16k |
| Income statement | ||
| Gross operating margin | 9900 | €254k |
| Operating result | 9901 | €27k |
| Financial income | 75 | €261 |
| Financial charges | 65 | €4k |
| Result before taxes | 9903 | €24k |
| Income taxes | 67/77 | €6k |
| Net result for the period | 9904 | €17k |
| Result to be appropriated | 9905 | €17k |
| NACE primary | 82990 |
| Legal form | Private limited company(610) |
| Incorporation | 27-06-2022 |
| Status | Active |
| Postal code | 7370 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 53020D1312/00M000 | Wallonia | 141 m² | 1 · 80 m² | 9.3 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
08-01-2024 Registered office moved from Boussu to Dour
- Rue Alfred Dendal 188/02 -7300 Boussu → Rue d'Offignies 84
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "Rue d\u0027Offignies 84",
"city": "Dour",
"region": "waals_gewest",
"street": "d\u0027Offignies",
"country": "BE",
"postcode": "7370",
"box_number": null,
"street_number": "84",
"locality_suffix": null
},
"old_address": {
"raw": "Rue Alfred Dendal 188/02 -7300 Boussu",
"city": "Boussu",
"region": "waals_gewest",
"street": "Alfred Dendal",
"country": "BE",
"postcode": "7300",
"box_number": "02",
"street_number": "188",
"locality_suffix": null
},
"effective_date": "2023-12-01",
"evidence_quote": "",
"region_changed": false,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "act_body",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "absolute",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-01-08",
"filing_date": "2023-12-01",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"date": "2023-12-30",
"unanimous": null
},
"subject_company": {
"kbo": "0787.678.897",
"name_full": "PHARMHELP",
"legal_form": "SRL",
"_kbo_filled_from_list": true
},
"publication_proxy": {
"kind": "org",
"org_kbo": "0562.992.552",
"org_name": "Compta FXT SPRL",
"person_name": null,
"org_rep_person_name": "Thimus Fran\u00E7ois-Xavier",
"person_role_at_subject": null
},
"co_filed_documents": [
"Mod DOO 19.01"
]
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | PHARMHELP |